Clinical Trials of Ixekizumab Offers New Hope to Many Patients with Psoriasis

by Dr. Trupti Shirole on  June 15, 2015 at 11:08 AM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Psoriasis is characterized by an abundance of skin cells that causes raised bumps known as 'plaques' to grow on the skin. These plaques can be flaky, scaly and itchy for sufferers. Clinical trials of a new drug ixekizumab has revealed that almost 40% of participants showed complete clearance of their plaques, while 90% experienced some improvement.
Clinical Trials of Ixekizumab Offers New Hope to Many Patients with Psoriasis
Clinical Trials of Ixekizumab Offers New Hope to Many Patients with Psoriasis

Researchers at the University of Manchester tested the effectiveness of the drug ixekizumab. Half of the study participants were given the new drug, ixekizumab while the other half were given a placebo, or a widely used drug for psoriasis called etanercept. The ixekizumab group showed quick and extensive improvements in their skin condition, outperforming the groups on placebo or etanercept. Around 50% of these patients showed improvement as early as week four of the trial and up to 71% had shown a high level of improvement in their symptoms.

Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Psoriasis Placebo Effects: Rare Insights Dry Skin Symptom Evaluation Foods that are Bad for your Skin Itchy Scalp 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...